drugset / Trial / NCT02836743

Effect of Slow-release Melatonin (Circadin®) Therapy on Idiopathic RBD: a Pilot Study

NCT02836743

Phase 4 Unknown 30 enrolled Seoul National University Hospital
RandomizedParallel-groupTriple-blindTreatment

Summary

To evaluate effect of slow-release melatonin (Circadin) on REM sleep behavior disorder.

Timeline

Start
2016-01
Primary completion
2017-12-31
Completion
2017-12-31

Drugs

EvaluationDrugModalityDoseRoute
Subject Melatonin Small molecule 2 mg
Subject Melatonin Small molecule 6 mg